article thumbnail

Episode 618: Does resistance against 1 antipseudomonal beta lactam mean the others can’t be used?

Pharmacy Joe

Finally, the study was sponsored by a pharmaceutical company that stands to benefit if fewer standard antipseudomonal beta lactam antibiotics are used. If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <–

article thumbnail

How early planning leads to successful market access and drug launch in Europe

Pharmaceutical Technology

Meanwhile, in Germany, the AMNOG process is conducted twelve months after the drug is launched, thus giving freedom to the company to set the drug’s price during this period. In addition, reimbursement schemes in European countries differ considerably between the outpatient and inpatient sectors.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Sanofi offers refunds for Cablivi in novel model for rebates

Pharmaceutical Technology

A refund up to 12 inpatient doses will also be offered for patients whose disease worsens while receiving treatment. Cournoyer highlighted that competitor products with long histories, guideline backing, and provider loyalty still pose a challenge for pharmaceutical companies testing innovative contracts.

article thumbnail

A New Pharmaceutical Product | Case Study

PharmaState Academy

Competitive Analysis: Evaluating the market share and brand presence of established pharmaceutical companies and generic drug manufacturers. Distribution Strategy: Establishing partnerships with leading hospital chains, clinics, and diagnostic centers for inpatient and outpatient sales.

article thumbnail

Enhancing Patient Care and System Revenue: The Case for Onsite Specialty Pharmacies in 340B Hospitals

Proxsys Rx

Additionally, by collaborating with pharmaceutical companies and academic institutions, onsite specialty pharmacies can facilitate the development of novel therapies — and participate in research initiatives that ultimately benefit patient care for everyone.

article thumbnail

Enhancing Patient Care and System Revenue: The Case for Onsite Specialty Pharmacies in 340B Hospitals

Proxsys Rx

Additionally, by collaborating with pharmaceutical companies and academic institutions, onsite specialty pharmacies can facilitate the development of novel therapies — and participate in research initiatives that ultimately benefit patient care for everyone.

article thumbnail

Enhancing Patient Care and System Revenue: The Case for Onsite Specialty Pharmacies in 340B Hospitals

Proxsys Rx

Additionally, by collaborating with pharmaceutical companies and academic institutions, onsite specialty pharmacies can facilitate the development of novel therapies — and participate in research initiatives that ultimately benefit patient care for everyone.